CE
CEN Biotech, Inc.
CENBF · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $6.53K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap P/S 0.01x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 50.45%
Net margin 153.48%
Op. margin 128.15%
Quality
2 /100
Poor ROIC 43.09%
ROA 19.28%
Asset turnover 0.13x
Debt
50 /100
Moderate Current ratio 0.03x
Int. coverage -4.99x
Net debt/EBITDA -6.65x
Stability
19 /100
Unstable Beta -4.98x
EPS volatility 219.27%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CENBF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Brian S. Payne
Employees
4
Headquarters
Windsor